Clinical Studies

Breast Care
Cardiology
Colon Cancer
Dermatology
Diabetes
Gastrointestinal
HIV/AIDS
Mental Health
Neurology
NeuroOphthalmology
Obesity/Weight Management
Women's Health
Other


Special Features
Advances/Research

 

A Multi-Center, Open-Label, Randomized Clinical Trial Comparing the Efficacy of Four Anti-Inflammatory Regimens in the Treatment Central Centrifugal Cicatricial Alopecia
Principal Investigator:   Andrew Alexis, MD
Co-investigators:  

Marcelyn Coley, MD
Sejal Shah, MD
John Seykora, MD

Time frame of study:   Ongoing
Time frame of participation:   Approximately 12 months
Number of participants needed:   20
Location of Study:  

Mount Sinai St. Luke's Roosevelt
1090 Amsterdam Avenue
Suite 11D
New York, NY 10025

Contact Name, Number & Email:   Clinical Research Offiice
(212) 523-4511
MColey@chpnet.org


Summary:
This is a multi-center, open-label, randomized, prospective study to compare the efficacy of four anti-inflammatory treatment regimens for the hair loss disorder, central centrifugal cicatricial alopecia (CCCA). The 48-week study will be divided into 2 phases: a 24 week Anti-Inflammatory phase (Phase 1) followed by a 24 week Stimulation of Growth phase (Phase 2). 20 female subjects will be recruited at each of 3 sites. Subjects will be followed for a minimum of 48 weeks with interval visit assessments after treatment is initiated for a minimum of 10 visits.

Criteria for Participation:
-Female patients of African descent
-Ages 18-65
-Progressive hair loss that began on top, central part of the scalp

Benefits/Compensation:
Evaluation and treatment by a board certified dermatologist